CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

EUROPE RESEARCH ROUNDUP-Avio, Genmab, Veolia

By Reuters News

Oct 26 (Reuters) - Securities analysts revised their and ratings price targets on several European companies including Avio, Genmab and Veolia on Monday.


HIGHLIGHTS


* Avio SpA AVI.MI: Berenberg raises to buy from hold

* Demant DEMANT.CO: RBC raises target price to DKK 384 from DKK 220

* Genmab GMAB.CO: JP Morgan raises to overweight from neutral

* Holcim Ltd. HOLN.S: Morgan Stanley raises target price to CHF 82 from CHF 79

* Veolia VIE.PA: Jefferies reinstates coverage with price target EUR 30


Following is a summary of research actions on European companies reported by Reuters on Monday Stock entries are in alphabetical order.

* Avanza Bank AVANZ.ST: JP Morgan cuts target price to SEK 397 from SEK 408.2

* Avio SpA AVI.MI: Berenberg raises target price to EUR 39 from EUR 33

* Avio SpA AVI.MI: Berenberg raises to buy from hold

* Be Semiconductor BESI.AS: HSBC cuts target price to EUR 169 from EUR 240

* Billerud AB (Publ) BILL.ST: Citigroup raises target price to SEK 90 from SEK 85

* Demant DEMANT.CO: RBC raises target price to DKK 384 from DKK 220

* Deutsche Boerse AG DB1Gn.DE: JP Morgan raises target price to EUR 347 from EUR 345

* Electrolux ELUXb.ST: JP Morgan cuts target price to SEK 34 from SEK 36

* Eurofins Scientific SE EUFI.PA: Jefferies raises target price to EUR 62 from EUR 58

* Evolution EVOG.ST: JP Morgan cuts target price to SEK 645 from SEK 660

* Genmab GMAB.CO: Jefferies raises target price to DKK 3,200 from DKK 2,900

* Genmab GMAB.CO: JP Morgan raises target price to DKK 3500 from DKK 2050

* Genmab GMAB.CO: JP Morgan raises to overweight from neutral

* Genmab GMAB.CO: TD Cowen raises target price to DKK 3,435.00 from DKK 2,892.00

* Holcim Ltd. HOLN.S: Morgan Stanley raises target price to CHF 82 from CHF 79

* Inchcape Plc INCH.L: Jefferies cuts target price to 930p from 1050p

* Interparfums SA IPAR.PA: Berenberg raises target price to EUR 40 from EUR 35

* Kerry Group Plc KYGa.I: JP Morgan raises target price to EUR 110 from EUR 105

* Orion ORNBV.HE: Jefferies raises target price to EUR 115 from EUR 77

* Orion ORNBV.HE: Jefferies raises to buy from hold

* Rexel RXL.PA: JP Morgan raises target price to EUR 46 from EUR 44.5

* Roche Holding AG ROPC.S: JP Morgan raises target price to CHF 335.00 from CHF 325.00

* Safran SAF.PA: Jefferies cuts target price to EUR 300 from EUR 340

* Safran SAF.PA: RBC cuts target price to EUR 375 from EUR 400

* Sartorius AG SATG.DE: Jefferies raises target price to EUR 253 from EUR 246

* Sartorius AG : Jefferies raises target price to EUR 315 from EUR 307

* Sartorius Stedim Biotech SA STDM.PA: Jefferies raises PT to EUR 266 from EUR 262

* SCA AB SCAb.ST: Jefferies cuts to hold from buy

* Sika AG SIKA.S: Morgan Stanley raises target price to CHF 196 from CHF 187

* Sika AG SIKA.S: RBC cuts target price to CHF 177 from CHF 179

* Sodexo EXHO.PA: Citigroup raises target price to EUR 65 from EUR 60

* Sodexo EXHO.PA: Jefferies raises target price to EUR 69 from EUR 65

* Sodexo SA EXHO.PA: Morgan Stanley raises target price to EUR 55 from EUR 50

* Telefonica TEF.MC: JP Morgan cuts target price to EUR 3.20 from EUR 3.70

* Telefonica TEF.MC: JP Morgan cuts to underweight from neutral

* Veolia VIE.PA: Jefferies reinstates coverage with price target EUR 30

* Veolia VIE.PA: Jefferies reinstates coverage with hold rating

* Volvo Car VOLCARb.ST: JP Morgan cuts target price to SEK 10 from SEK 18

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.